Related Experiment Video
Updated: Jun 3, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Distribution of bleomycin in a rat model
P Engström1, L G Salford, B R Persson
1Department of Radiation Physics, Lund University Hospital, Lund, Sweden.
Methods in Molecular Medicine
|March 30, 2011
Summary
Bleomycin is a potent chemotherapy drug frequently used with electrochemotherapy (ECT) for cancer treatment. This study investigates bleomycin
Area of Science:
- Oncology
- Pharmacology
- Cancer Therapeutics
Background:
- Bleomycin is a widely used and effective chemotherapeutic agent.
- Electrochemotherapy (ECT) is a cancer treatment modality that enhances drug delivery.
- Bleomycin is the most common agent used in ECT.
Purpose of the Study:
- To investigate the pharmacokinetics of bleomycin.
- To understand bleomycin behavior under normal conditions.
- To analyze bleomycin pharmacokinetics specifically during ECT.
Main Methods:
- Pharmacokinetic analysis of bleomycin.
- Comparative study of bleomycin behavior with and without ECT.
Main Results:
- Detailed pharmacokinetic data for bleomycin was collected.
- Specific alterations in bleomycin pharmacokinetics during ECT were identified.
Conclusions:
- Bleomycin exhibits specific pharmacokinetic properties.
- Understanding these properties is crucial for optimizing ECT efficacy.
- Further research can refine bleomycin-based cancer therapies.
